TrialObesity (Silver Spring, Md.)2013

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II).

Caroline M Apovian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.